M-alpha-HMCA
Chemical compound / From Wikipedia, the free encyclopedia
M-alpha-HMCA (3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide) is an unintentional sideproduct during the synthesis of MDMA using PMK glycidate as a precursor. It was identified in MDMA pills.[1] The biological properties of this molecule have not yet been documented. The backbone of the chemical structure is M-alpha whose psychoactive activity has been described by Alexander Shulgin.[citation needed]
This article needs additional citations for verification. (June 2020) |
Quick Facts Identifiers, Chemical and physical data ...
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C13H18N2O4 |
Molar mass | 266.13 g/mol (freebase) 239.78 g/mol (hydrochloride) g·mol−1 |
3D model (JSmol) | |
| |
|
Close